Fact Sheet

Etubics initiated pre-clinical studies of its products in 2006
Etubics is developing commercial prophylactic vaccines and immunotherapy products
9 employees
Corporate headquarters in Seattle, Wash.
Etubics is in Phase I/II human clinical trials for colon cancer immunotherapy